Sugammadex 500mg/5ml solution for injection vials
NHS hospitals in England used £15,062,793 of indicative cost of Sugammadex 500mg/5ml solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 45.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Sugammadex 500mg/5ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Sugammadex 500mg/5ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| South Tyneside And Sunderland Nhs Ft | £688,317 |
| Imperial College Healthcare Nhs Trust | £685,148 |
| Nottingham University Hospitals Trust | £497,692 |
| Calderdale & Huddersfield Nhs Found Tr | £464,104 |
| Co.durham & Darlington Nhs Foundation Tr | £450,269 |
| York Teaching Hospital Nhs Ft | £426,481 |
| James Paget Univ Hospitals Nhs Ft | £424,871 |
| Aintree University Hospital Nhs Ft | £422,313 |
| Derby Teaching Hospitals Nhs Found Trust | £415,126 |
| Walsall Healthcare Nhs Trust | £406,160 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.